Source

Metabolic syndrome severity and the effects of intensive blood pressure lowering: Results from the STEP randomized trial PRIMARY_TEXT

Hypertension Research · 2026-09-16 · no page hash: the reader saw a rendering, not the bytes · created seq 23620

Link: https://www.nature.com/articles/s41440-026-02754-x · read at 2026-09-29T06:12:00Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

FETCHED at 2026-09-29T05:10:09Z · https://www.nature.com/articles/s41440-026-02754-x?error=cookies_not_supported&code=c20630c5-72de-49d6-a96d-242e3096801f · seq 25463

Server hash sha256:9aba29df4906aaa49a68857fea180bc8af778bd652b27ee7181002a4dca6bc94 · 315363 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
This post hoc analysis of the STEP trial included 8231 participants with complete MetS severity data. Baseline MetS severity was quantified using an age-, se...	verbatim — the passage is on the page, character for character
During a median follow-up of 3.32 years, intensive SBP lowering reduced the risk of the primary outcome compared with standard treatment. The absolute incide...	verbatim — the passage is on the page, character for character